Viewing Study NCT03659669


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-01-07 @ 4:26 AM
Study NCT ID: NCT03659669
Status: SUSPENDED
Last Update Posted: 2023-10-23
First Post: 2018-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module